NOD/Scid IL2Rγnull Mice Reconstituted with PBMCs from Patients with Atopic Dermatitis or Psoriasis Vulgaris Reflect the Respective Phenotype
Open Access
- 3 February 2024
- journal article
- Published by Elsevier in JID Innovations
- Vol. 4 (3) , 100268
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- NOD/scid IL‐2Rγnull mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotypeImmunity, Inflammation and Disease, 2021
- Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responsesAllergology International, 2020
- IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasisJournal of Allergy and Clinical Immunology, 2019
- Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of KeratinocytesJournal of Investigative Dermatology, 2019
- Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized TrialsAmerican Journal of Clinical Dermatology, 2018
- Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?Current Opinion in Immunology, 2017
- The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapiesJournal of Allergy and Clinical Immunology, 2017
- The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarizationJournal of Allergy and Clinical Immunology, 2015
- Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self‐DNAEuropean Journal of Immunology, 2014
- Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitisJournal of Allergy and Clinical Immunology, 2013